PharmiNews

The Directory of Pharma Companies and News

Allergan

Allergan logo
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a unique, global pharmaceutical company and a leader in a new industry model - Growth Pharma. Allergan is focused on developing, manufacturing and commercializing innovative branded pharmaceuticals, high-quality generic and over-the-counter medicines and biologic products for patients around the world. Allergan markets a portfolio of best-in-class products that provide valuable treatments for the central nervous system, eye care, medical aesthetics, gastroenterology, women's health, urology, cardiovascular and anti-infective therapeutic categories, and operates the world's third-largest global generics business, providing patients around the globe with increased access to affordable, high-quality medicines. Allergan is an industry leader in research and development, with one of the broadest development pipelines in the pharmaceutical industry and a leading position in the submission of generic product applications globally. With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives.
Category: Pharmaco
Category: Pharmaco

Allergan News

DateNews
2017-05-23Allergan Announces Commencement of Proposed Public Offering of Senior Notes to Refinance Existing Debt
2017-05-16Allergan's Eyepowerment™ Campaign Releases Survey Revealing the Importance of Eye Language and the Crucial Role it Plays...
2017-05-15Allergan to Present at the Bernstein Strategic Decisions Conference
2017-05-10Allergan Announces Tender Offers by Certain Subsidiaries
2017-05-10Allergan Announces Proposed Public Offering of Senior Notes to Refinance Existing Debt
2017-05-09Allergan Reports Solid Start to 2017 with 5% Increase in First Quarter GAAP Net Revenues to $3.6 Billion
2017-05-05Allergan Announces Second Quarter 2017 Cash Dividend of $0.70 Per Ordinary Share
2017-05-04Allergan to Present at the Bank of America Merrill Lynch Healthcare Conference
2017-05-04Allergan to Present New Data at the 2017 American College of Obstetricians and Gynecologists (ACOG) Clinical and Scienti...
2017-05-02Allergan Solidifies Strong Footprint at ARVO 2017 with Several Data Presentations
2017-05-01Allergan to Present New and Updated Linzess®, Viberzi®, Relamorelin, Linaclotide Delayed Release, and Cenicriviroc Data ...
2017-04-28Allergan Successfully Completes ZELTIQ® Aesthetics Acquisition
2017-04-25Allergan Granted Marketing Authorization by the FDA for TrueTear™, the First Intranasal Neurostimulating Device Proven t...
2017-04-20Allergan Announces 13 Presentations on Chronic Migraine, Upper and Lower Limb Spasticity, Cervical Dystonia and Alzheime...
2017-04-20Allergan Partners with TARGET PharmaSolutions to Advance NASH Research
2017-04-18Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration
2017-04-13Allergan and Ironwood Launch Campaign Designed to Empower the Nearly 64 Million Americans Estimated to Suffer from IBS a...
2017-04-11Allergan Launches Frames of Mind, Encouraging People Living with Migraine to Share Common Experiences Through Art
2017-04-10Allergan Receives 2017 ENERGY STAR® Partner of the Year - Sustained Excellence Award from U.S. Environmental Protection ...
2017-04-07Allergan Teams Up With Media Mogul Wendy Williams to Debut the Patient Empowerment Campaign - Toilet Talk
2017-04-06Allergan Names Daphne Karydas as Senior Vice President of Global Investor Relations & Strategy
2017-04-06Allergan and ZELTIQ Announce Expiration of Hart-Scott-Rodino Waiting Period for Pending Transaction
2017-04-05Allergan Reports Topline Phase II Data Supporting Advancement of BOTOX® (onabotulinumtoxinA) for the Treatment of Major ...
2017-01-09Allergan Enters Parkinson's Disease Through Option Arrangement with Lysosomal Therapeutics Inc. (LTI) for its Potential ...
2017-01-09Allergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointest...
2017-01-05Allergan to Present at Goldman Sachs Healthcare CEOs Unscripted Conference and Provides Preliminary Comments on 2017 Out...
2017-01-04FDA Accepts For Filing Supplemental New Drug Application (sNDA) For LILETTA® (levonorgestrel-releasing intrauterine syst...
2017-01-03Allergan to Present at 35th Annual J.P. Morgan Healthcare Conference
2017-01-03Allergan Announces FDA Approval of NATRELLE INSPIRA® SoftTouch Breast Implants
2016-12-22Allergan plc Board of Directors Issues Statement on Company's Social Contract with Patients
2016-12-22Ironwood and Allergan Report Topline Phase IIb Data Supporting Further Investigation of Linaclotide Colonic Release-2 (C...
2016-12-22Ironwood and Allergan Report Topline Phase IIb Data Supporting Advancement of Linaclotide Colonic Release-1 (CR1) in IBS...
2016-12-21Allergan to Present at Goldman Sachs Healthcare CEOs Unscripted Conference
2015-03-17Actavis Completes Allergan Acquisition
2015-03-16European Commission Clears Actavis' Pending Acquisition of Allergan
2015-03-10Actavis and Allergan Shareholders Approve Proposals Related to Actavis' Planned Acquisition of Allergan
2015-03-02DEMAND FOR HYALURONIC ACID FACIAL FILLERS IN THE U.S. INCREASES BY 8 PERCENT
2015-02-27FDA Approves Allergan's NATRELLE INSPIRA™ Round Gel-Filled Breast Implants
2015-02-04Allergan Reports Fourth Quarter 2014 Operating Results
2015-01-26Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC
2015-01-12Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis' Pending Acquisition of ...
2014-11-17Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue
2014-11-14Physicians Continue to Voice Strong Support for Allergan via Open Letters to the Eye Care Community
2014-11-12FDA Approves New Styles of Allergan's NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants
2014-11-12Allergan Board of Directors Announces Approval of Amendments to Company's Bylaws
2014-11-11New Survey Reveals What Women in the U.S. Really Want to Know About BOTOX
2014-11-05New Survey Shows Nearly 60% Of Women Say They Would Rather Have A More Youthful Looking Face Than A More Youthful Lookin...
2014-11-04Allergan Comments on California Federal Court Ruling in Insider Trading Lawsuit Against Valeant & Pershing Square
2014-10-28New Allergan Campaign #THISISME Empowers Women To Age The Way They Want
2014-10-27Allergan Comments on Valeant Letter
2014-10-27Allergan Reports Third Quarter 2014 Operating Results
2014-10-24Allergan Announces Quarterly Conference Call
2014-10-15Harvard Business Review Ranks David Pyott One of the Top 5 CEOs in the World
2014-10-09Allergan Provides Update on Earnings Per Share and Sales Expectations
2014-09-29Allergan Announces FDA Approves Revised Indication for OZURDEX® (dexamethasone intravitreal implant) 0.7 mg for the Trea...
2014-09-29Allergan Board of Directors Issues Statement
2014-09-25Allergan Issues Statement Regarding Recent Valeant Correspondence
1970-01-01Amgen and Servier extend Omecamtiv Mecarbil collaboration in Chronic Heart Failure
1970-01-01Mundipharma International appoints Paul Medeiros to head its corporate and business development operations (PDF)
Brought to you by PharmiWeb.com - Latest Jobs in Pharma
Brought to you by www.pharmiweb.com - Latest Jobs in Pharma.
E_CORE_WARNING Error in file Unknown at line 0: PHP Startup: Invalid library (appears to be a Zend Extension, try loading using zend_extension=opcache.so from php.ini)